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Albendazole is an effective antihelmintic drug, which has an unpredictable therapeutic response due 
to its low solubility in biological fluids that limits its oral absorption. In an attempt to improve solubility, 
Albendazole Hydrochloride, a soluble pharmaceutical salt, was obtained and characterized by X-ray 
diffraction together with magic angle spinning solid-state nuclear magnetic resonance spectroscopy, 
Raman and Fourier transform infrared spectroscopies, thermal analysis, energy-dispersive X-ray 
spectroscopy and scanning electron microscopy. These studies revealed that the crystalline habit 
of Albendazole Hydrochloride is different from that of the Albendazole solid forms previously 
reported. Full structure was elucidated by performing single-crystal X-ray diffraction. The 
characterization studies showed the participation of the carbamate moiety in the salt formation. In 
addition, the solubility studies showed a significant increase in solubility with respect to forms I and 
II of Albendazole. In conclusion, our results point to that Albendazole Hydrochloride can be an 
auspicious salt to be used as a new product in an attempt to counteract unfavorable pharmaceutical 
properties.
KEYWORDS: Albendazole Hydrochloride, characterization, X-ray diffraction, solid-state nuclear 
magnetic resonance, solubility
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The soil-transmitted helminthiasis is a constant concern within public health, affecting the vulnerable 
socioeconomic sectors with high impact. These parasitic infections are endemic and widely 
distributed in tropical and subtropical areas, affecting more than 1.5 billion people worldwide. These 
helminthiasis cause alterations in the nutritional, cognitive and physical development of the 
population, so their treatment should be essential and priority.1-4
Benzimidazole derivatives are the most used compounds with acceptable antihelminthic efficacy.  
Albendazole (ABZ), one of the drugs of choice, displays a broad spectrum of antihelminthic action, 
interfering with microtubule assembly and blocking glucose uptake in many intestinal and tissue 
nematodes and some cestodes.5-7 It is widely used by oral administration; however, its efficacy is 
often limited by its poor absorption in the gastrointestinal tract, due to its poor aqueous solubility and 
its slow rate of dissolution. Therefore, treatments with high doses are required, which often have 
undesirable side effects associated.8,9 Two solid forms, designated ABZI and ABZII, which have 


















Scheme 1. Chemical structure of ABZ along with the atom numbering adopted.
In order to counteract the negative properties of ABZ and optimize the chemotherapeutic treatment, 
the development of innovative systems for an adequate therapy is of relevant importance for the 
pharmaceutical sciences. Different strategies have been studied, such as complexation with 
cyclodextrins11-14 or maltodextrins,15 solid dispersions,16,17 and nanocrystals18 among others. 
Another effective option is the incorporation of pharmaceutically acceptable coformer agents that do 
not alter the covalent bond of the drug.19 In this context, the formation of soluble salts can be a 
promising solution. Particularly, the amine salts are more soluble than their precursor and less 
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susceptible to decomposition by oxidation and other reactions. For this reason, many active 
pharmaceutical ingredients are formulated and stored as their salts. In addition, the hydrochloride 
salts are the most used in the pharmaceutical industry.20 
In the literature, Albendazole salts were obtained using a variety of possible counterions: 
hydrochloric acid, methane sulfonic acid, sulfuric acid and para-toluene sulfonic acid.21,22 Also, salts 
and salt hydrates with sulfonic acids (benzene and p-toluene sulfonic acid) and carboxylic acids 
(oxalic acid, maleic acid, L-tartaric acid, 2,6-dihydroxybenzoic acid and 2,4,6-trihydroxybenzoic 
acid) were reported.23 Based on their characterization studies some differences between them were 
evidence. 
The aim of the present study was to obtain a soluble salt of ABZ that allows optimizing its 
biopharmaceutical properties. Albendazole Hydrochloride (ABZ-Cl), a stable and soluble salt, was 
synthesized, isolated and physicochemically characterized with various techniques, evaluating its 
effect on the solubility. 
2. EXPERIMENTAL SECTION
Chemicals and Reagents
Albendazole (ABZ) was provided by Todo Droga (Argentina). Methanol and hydrochloric acid, 
analytical reagent grade chemicals, were obtained from Cicarelli (Argentina). A Millipore Milli Q 
Water Purification System (Millipore, Bedford, MA, USA) generated the water used in these studies. 
All other chemicals were of analytical grade. 
Obtaining Albendazole Hydrochloride
In an attempt to produce ABZ-Cl, ABZ form I (approximately 10 mg) was dissolved in 10 mL of a 
solution of hydrochloric acid (0.084 M) in methanol at room temperature, and then allowed to a slow 
complete evaporation of the solvent. Pink crystals were collected after 5-6 days. 
X-ray Diffraction measurements
The diffraction data from ABZ-Cl crystals were collected on a Bruker D8 VENTURE Kappa geometry 
diffractometer, equipped with a PHOTON II CPAD detector, a MoKα INCOATEC IS 3.0 microfocus 
source (λ = 0.71073 Å) and APEX 3 control software.24 Data reduction was performed using SAINT24 
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and the intensities were corrected for absorption using SADABS. 25 Using Olex2,26 the structure was 
solved by intrinsic phasing using SHELXT27 and refined by full-matrix least squares using 
SHELXL.28, 29 All non-hydrogen atoms were refined anisotropically. Hydrogen atom positions were 
calculated geometrically and refined using the riding model. The crystallographic information file of 
ABZ-Cl crystal was deposited in the Cambridge Structural Data Base,30,31 under code CCDC 
1879541. Copies of the data can be obtained, free of charge, via www.ccdc.cam.ac.uk.
Powder X-ray diffraction (PXRD) patterns were obtained at ambient temperature using a Philips 
PW1710 diffractometer operating at 45 kV and 30 mA with Cu-Kα radiation. The powder pattern was 
collected by scanning 2 from 2° to 40° with a step size of 0.05° at a scanning rate of 2.5 
seconds/step, at the initial time and after six months of storage.
Solid-State NMR Spectroscopy (ssNMR)
All ssNMR experiments were performed at room temperature in a Bruker Avance II spectrometer, 
operating at 300.13 MHz for protons, equipped with a 4 mm MAS probe. Ramp cross 
polarization/magic angle spinning (CP-MAS) sequence with proton decoupling during acquisition 
was used to obtain high resolution solid state 13C spectra of ABZ-Cl.32,33 The compound was 
evaluated at two different times (initial time and after six months of storage). The operating frequency 
for carbons was 75.46 MHz, using Glycine as an external reference. Spectra were recorded with 
1600 scans, setting a contact time of 1.5 ms and a recycling time of 5 s. SPINAL-64 was used for 
proton decoupling during acquisition.34 The edition spectrum containing quaternary carbons and 
methyl groups was also recorded.32 The spinning rate in these experiments was set to 10 kHz.
2D 1H -13C heteronuclear correlation (HETCOR) spectrum was recorded at 10 kHz MAS following 
the sequence presented by van Rossum et al.35 The pulse sequence starts with a train of off-
resonance frequency-switched Lee−Goldburg (FSLG) pulses in a tilted frame at the magic-angle, to 
cancel the first two terms of the homonuclear dipolar coupling Hamiltonian. FSLG irradiation was 
applied during the t1 evolution period in successive times τ. A ramped-amplitude CP sequence 
enhanced 13C signals, and the SPINAL-64 decoupling was also used during 13C acquisition. The 
period τ was set to 7.68 μs. The CP contact time was set to 200 μs to avoid homonuclear spin-
diffusion, and the recycle delay was 5 s. Magic-angle pulse was set to 2.55 μs. Sixty-four t1 
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increments with a dwell time of 35.5 μs, corresponding to a total acquisition time of 1.14 ms, were 
used. 
Raman spectroscopy
Raman spectra were recorded on a LabRAM HR (Horiba) spectrometer equipped with a liquid N2-
cooled CCD detector using a near infrared laser (785nm) for excitation, with a power of 100 mW. 
The spectral region studied was 50-4000 cm-1 and the measurements were carried out using a 50x 
NIR microscope objective, with an acquisition time of 150 s by region.
Fourier-transform infrared spectroscopy (FT-IR)
The FT-IR spectra were recorded on a Nicolet 5 SXC FT-IR Spectrophotometer (Madison, WI, USA), 
with potassium bromide disks prepared by compression.
Thermal analysis
Simultaneous differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) 
experiments were performed on a Jupiter STA 449 F3 Jupiter (Netzsch) system. Measurements 
were obtained over a temperature range of 30-450 ºC using a heating rate of 10°C.min-1 and a 
sealed aluminum crucible with pierced lids containing 5 mg of sample. The sensors and the crucibles 
were under a constant flow of nitrogen (70 mL/min) during the experiment.
Scanning electron microscopy studies (SEM) - Energy-dispersive X-ray spectroscopy (EDS)
Microscopic morphological structure of the solid-state sample was investigated and photographed 
using a Carl Zeiss Sigma scanning electron microscope. The sample was fixed on a brass stub by 
means of a double-sided aluminum tape, which was gold-coated under vacuum using a sputter 
coater Quorum 150 to improve the conductivity. The EDS spectrum was acquired using an Oxford 
energy dispersive silicon drift detector, which has an X-ray detector attached to it, an 80-mm2 front 
area and a 127 eV nominal resolution for Mn-Kα line. The chemical composition of the sample was 
identified using an external PC.
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The apparent solubility of ABZ-Cl in aqueous solution, simulated gastric fluid (SGF) and simulated 
intestinal fluid (SIF) was studied. An excess of ABZ-Cl (approximately 20 mg) was placed in 
stoppered tubes containing 5 mL of each media. The suspensions were agitated in an ultrasonic 
bath (Elmasonic S40) and then maintained at 37.0 ± 0.1 ºC for 72 h in a constant-temperature water 
bath (Pilot One, Huber). After that, the remaining solid was removed by filtration through a 0.45 m 
membrane filter (Millipore, USA). The clear solutions were suitably diluted and analyzed by UV-Vis 
spectrophotometry (Agilent Cary 60 spectrophotometer) at  = 292 nm.
3. RESULTS AND DISCUSSION
Solid-State Characterization 
In order to characterize and unequivocally distinguish the solid sample ABZ-Cl, several 
complementary techniques such as X-ray diffraction experiments, ssNMR, Raman and FT-IR 
spectroscopy, DSC, TGA, EDS and SEM were used. The results were compared with those 
obtained for the characterization of both ABZ solid forms (ABZ I and ABZ II) in our previous 
reports.10,15
Single-Crystal X-ray diffraction
Adequate fragments from single-crystal samples were selected and used as material for the 
experiments. We determined that ABZ-Cl crystallizes in a triclinic system with  space group, and 𝑃1
two molecules per unit cell and the following lattice parameters: a=7.5578(5) Å, b=7.7829(5) Å, c = 
12.8313(9) Å,  = 78.980(2)o; = 84.596(2)o and  = 79.119(2)o (Table S1). Figure 1 shows the 
thermal ellipsoid representations of the molecular structure for ABZ-Cl, together with atomic 
numbering scheme. The asymmetric unit is characterized by the disorder of the propanethiol tail, as 
well as, a slight positional disorder of the chlorine ion. Since the compound crystallizes as a salt, all 
nitrogen atoms are protonated. The carbamate tail is aligned in the plane of the aromatic rings by 
the intramolecular hydrogen-bond N1H1∙∙∙O12 (2.764(2) Å).    
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Figure 1. ORTEP plot of ABZ-Cl drawn at 50% probability level.
Figure 2a shows the unit cell of ABZ-Cl, where the two molecules in the unit are aligned antiparallel, 
with their aromatic rings lying approximately parallel to the (101) plane. The crystalline structure is 
stabilized by chains along the [010] direction, where ABZ and Cl are alternated and linked by 
hydrogen-bonds. On one side of the ABZ molecule, there is a bifurcated hydrogen bond 
N3H3∙∙∙ClA/B (3.100(5)/3.023(16) (Å) and N10H10∙∙∙ClA/B (3.129(5)/3.05(2) Å). The following ABZ 
molecule is linked to Cl by a single bond N1H1∙∙∙ClA/B (3.154(5)/3.18(2) Å), as shown in Figure 2b. 
This packing differs from the one observed in ABZ polymorphs, whose main features are ABZ  𝑅22(8)
dimers based on NH∙∙∙N bonds.36 A similar packing is observed in the polymorphs of mebendazole, 
another benzimidazole carbamate derivative.37 In fact, those dimers are also disrupted by an halide 
cation in mebendazole hydrochloride and hydrobromide salts, which exhibit the same alternated 
chains as ABZ-Cl.38, 39 
The alternated chains are stacked linked by - interactions, as it is clearly evidenced by the 
Hirshfeld surface mapped with the shape index40 presented in Figure 3. The complementary red and 
blue triangles in a ‘bow-tie’ pattern on the surface are well-known markers of close C…C interplanar 
contacts characteristic of a - bond.41 Thus, on one side of the ABZ molecule, the antiparallel 
chains are linked by a - bond connecting the six-membered rings (Figure 3a), whose centroids 
are separated by 3.7051(13) Å. On the other ABZ side, three ‘bow-tie’ patterns can be identified 
(Figure 3b). Two of them are related to the phenyl-imidazol - bond (3.5814 (11) Å), while the third 
is associated to the bond between imidazole rings (3.5482(11) Å). Similar - interactions can be 
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identified in the mebendazole hydrochloride and hydrobromide salts,36,37 being a characteristic of 
the packing of the antiparallel chains in benzimidazole carbamate derivative inorganic salts.
Figure 2. (a) Unit cell and (b) alternated chains along the b-axis of ABZ-Cl. 
Figure 3. Shape index mapped Hirshfeld surfaces for the asymmetric unit of ABZ-Cl projected along 
the stacking direction. An additional ABZ molecule was included on (a) top and (b) bottom to 
emphasize - stacking interactions.
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PXRD patterns, shown in Figure 4, were obtained from powder samples in order to examine other 
aspects of ABZ-Cl powder, and differentiate it from I and II solid forms of ABZ. The diffractogram of 
ABZ-Cl showed a crystalline structure. However, by comparing its pattern with the ones of the ABZ 
desmotropes10, it was confirmed that this salt crystallizes in a different structure. Recrystallized 
hydrochloride evidenced clear differences in intensity and sharp peaks. The pattern displayed peaks 
located at 7.2°, 11.8°, 12.7°, 14.2°, 19.1°, 22.5°, 23.5°, 23.8°, 25.8°, 26.9°, 28.8°, 30.3°, 31.7°, 32.8° 
and 33.9° (2), evidencing the formation of other crystal ABZ form. In addition, this powder pattern 
exhibits a strong correlation with the one calculated by single-crystal X-ray diffraction. Additionally, 
the influence of environmental temperature on the crystalline form was evaluated by means of a 
complementary stability testing. Therefore, ABZ-Cl samples were stored in containers protected 
from light at room temperature. The PXRD patterns, performed after 180 days of storing, showed 
the characteristic peaks of the crystalline salt, evidencing the physical stability of the sample when 
it was stored at room temperature. ABZ-Cl conserves its crystalline status.





Figure 4. Powder X-ray diffraction patterns of ABZ-Cl, ABZI and ABZII.
1D and 2D ssNMR
Figure 5 displays the 13C CP-MAS spectrum of ABZ-Cl in comparison with the previous reported 
solid forms ABZ-I and ABZ-II.10 Assignments were made according to the quaternary and methyl 
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group carbon edition spectrum (Figure S1 of Supporting Information) and considering the reported 
solid state 13C NMR spectra of the ABZ desmotropes. HETCOR experiment was also helpful in 
identifying some 13C peaks (see Figure 6 below). Table S2, in Supporting Information, contains the 
13C chemical shifts for the assigned resonances in ABZ-Cl.
As a result of the changes in almost all of the resonances with respect to previously reported solid 
forms, it was possible to affirm that ABZ-Cl is a new solid form. Consider for example, C14 that 
appeared at 53.3 and 52.1ppm for ABZ-I and II, respectively, in which case its resonance was at 
56.2 ppm in the salt. Other important notable shift occurred in C11, being at 152.1 ppm in ABZ-Cl 
and at around 160.6 ppm or 162 ppm in forms I and II. Then, considering NMR point of view, ABZ-
Cl does not contain traces of the other solid forms (I and II) at least at the noise level. Note that 
particular splitting observed in resonances of C6 and C9, and a shoulder in C16, are probably due 
to the presence of two molecules per unit cell, as it was observed from single-crystal X-ray 
diffraction. In addition, different samples of ABZ-Cl were monitored after six months of storage 
showing the same 13C spectra, confirming the stability of the sample during that time. 
Figure 5.  13C CP-MAS spectra of ABZ-Cl, ABZ-I and ABZ-II. Numbering of peaks in spectra 
corresponds to that in Scheme1. 
Figure 6 shows the 2D 1H-13C HETCOR NMR spectra for ABZ-Cl. A short contact time of 200 μs 
was used during the CP period allowing only the development of short-range heteronuclear 
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interactions. The carbon spectrum is shown in the direct projection (horizontal, F2), while the proton 
spectrum is shown in the indirect dimension (vertical, F1). The clear correlations observed between 
carbons and their neighbouring protons allowed to extract the proton chemical shifts (see Table S3 
in Supporting Information). The 2D spectrum reveals particular inter and intra-molecular correlations, 
being distinguished from the ones observed for the solid forms I and II of ABZ.10 
Figure 6. Two-dimensional 1H-13C HETCOR spectrum of ABZ-Cl. 13C and 1H projections are 
displayed in the direct and indirect frequency dimensions, respectively. Assignments are shown for 
the carbon and proton spectra.
In particular, there are clear correlations between tail carbons and their corresponding protons. 
Considering higher ppm signals that belong to NH groups, note the particular correlations, N-H10 
with C11, and N1 and N3 with C2. These observations confirm the fact that all nitrogen atoms are 
protonated, as it was observed from single-crystal X-ray diffraction.  In addition, carbons C4, C5 
could be assigned from the correlations with H1, H3.
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Raman and FT-IR spectroscopy
Raman and FT-IR were performed to analyze the structural changes related to the salt formation, 
since some characteristic vibrational states may be affected. Therefore, the substantial differences 
between the spectra of ABZ I and ABZ II desmotropes10,15 and ABZ-Cl were investigated. 
The Raman spectrum of ABZ-Cl exhibited significant spectral differences in the 150–700 cm−1 and 
1400 and 1800 cm−1 regions with respect to the spectra of the solid forms I and II of ABZ 15 (Figure 
7). It was possible to identify and unequivocally distinguish this salt from ABZ I and ABZ II. 
Figure 7.  Raman spectra of ABZ-Cl, ABZ I and ABZ II.
The FT-IR spectra (Figure 8) revealed additional evidence to distinguish between the solid forms of 
ABZ. The assignment of the FT-IR bands for ABZ-Cl are shown in Table S4 (Supporting 
Information). By comparing the signal spectra, it is possible to observe the N–H stretching vibration 
intense band localized at 3325 cm-1 in the ABZ desmotropes; however, a weak N–H stretching band 
is observed at lower frequency (3080 cm-1) in the ABZ-Cl spectrum. Additionally, the band 
corresponding to the carbonyl group of the carbamate moiety appeared shifted to higher frequency 
(1750 cm-1) with respect to the ABZ desmotropes.10 The CH3 absorption appeared as two bands at 





2500 3000 3500 4000
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1440 and 1489 cm-1, and the C=N stretching bands are localized at 1640 and 1573 cm−1. In addition, 
the bands in the fingerprint region (between 1500 and 600 cm−1) show marked differences.
In addition, the C=O frequency shift is comparable to the observed for ABZ salt with L-Tartaric acid 
and salts hydrates with benzene and oxalic acid,23 which indicate a stronger hydrogen bonding. This 
spectral modification of ABZ-Cl confirms the intramolecular hydrogen-bond N1H1∙∙∙O12 observed 
from single-crystal X-ray diffraction, unlike hydrogen bonds that connect the molecules in the salts 
reported by Bolla and Nangia.23  
In this study, the analysis of spectral Raman and FT-IR differences observed for ABZ-Cl with respect  
to ABZI and ABZII forms and other salts, previously reported, evidenced that the N–H group of the 
carbamate moiety is involved in the salt formation, suggesting that the hydrogen of the HCl is 






Figure 8.  FT-IR spectra of ABZ-Cl, ABZ I and ABZ II.
Thermal analysis
The thermal behavior of solid salt was investigated. The DSC and TGA profiles of ABZ-Cl are shown 
in Figure 9. 
The DSC profile of ABZ-Cl showed the following transitions: an endothermic event at 105°C 
associated with a mass loss of 3.1% in TGA curve, which can be assigned to the loss of superficial 
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adsorbed solvent remaining from the synthesis which could be treated of adsorbed water; the next 
endothermic signal with peak at 173.1 °C (onset at 159.6 °C) and a weight loss of 15.2% in TGA, 
which is close to the theoretical value expected for the release of HCl (~13%); and the last mass 
loss of 40.5% beginning at 275°C along with the corresponding endotherm peak at 320.4 °C, which 
is attributed to the decomposition of ABZ. However, by comparing the thermal curves, a lower 
thermal stability for the salt ABZ-Cl with respect to ABZ I and ABZ II desmotropes was evidenced.
Figure 9.  DSC and TGA curves of ABZ-Cl (green), ABZ I (red) and ABZ I (blue).
SEM
The SEM microphotographs (Figure 10) were used to examine the morphological aspect of the salt 
and, additionally, evaluate differences with respect to forms ABZ I and ABZ II previously reported.15 
The microscopic appearance of the solid offered supporting evidence on the formation of a different 
solid phase. The images revealed that the size and shape of the particles are very different from 
each solid. In particular, ABZ-Cl showed a crystalline structure of regular compact particles with rod-
like shape and smooth surface, which are adhered adopting a morphology of the starry type. While 
ABZ I showed irregular particles of different sizes and shapes forming aggregates, ABZ II existed 
as self-agglomerate lamellar particles.15
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a b c 
Figure 10. SEM microphotographs of: a) ABZ-Cl, b) ABZ-II and c) ABZ-I.
EDS
EDS, a chemical microanalysis technique,42 was used in conjunction with SEM to determine the 
chemical composition of the ABZ-Cl salt. Figure 11 shows the imaging results: spectrum of X-ray 
energy versus counts and the chemical map for Cl. 
EDS analysis evidenced the elemental composition of the sample: C, O, N, S and Cl, confirming 
that the sample is a hydrochloride salt. In addition, the photomicrograph shows a homogeneous 
distribution of element Cl in the sample.
Figure 11. EDS spectrum for ABZ-Cl and chemical map for Cl.
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The apparent solubility of ABZ-Cl was evaluated at 37.0 ± 0.1 °C. Table 1 summarizes the results 
obtained in aqueous solution (pH 6.2), SGF (pH 1.2), and SIF (pH 6.8). The solubility data showed 
that ABZ-Cl is significantly more soluble than the ABZ desmotropes (Figure 12), demonstrating that 
this salt significantly improves the solubility of the drug at low pH values. In particular, the solubility 
of ABZ-Cl in aqueous solution showed an increase of 30 times with respect to ABZ I and 15 times 
for ABZ II.11 
ABZ is weakly basic in nature, which has pKa values of 2.68 and 11.83. From the solubility values, 
the effects of the ionization associated with the pH can be observed. The results revealed the highest 
solubility in SGF due to the presence of the molecule in its ionized state, while in aqueous solution 
at final pH 3.8, ABZ-Cl was less soluble, which could be assigned to the presence of a more lipophilic 
species. On the other hand, a lower solubility of the salt in SIF was determined, with the appearance 
of a white precipitate during the time necessary to reach the solubility equilibrium. This behavior can 
be associated with the ionic equilibrium at pH 6.8, with ABZ in low percentage as ionized form. In 
addition, the potassium ions of buffer could act as counterion of the chloride ion, since potassium is 
more electropositive than nitrogen, interfering with the amine-chloride association.43 Therefore, the 
salt formation is disfavored in alkaline solution, in fact it was confirmed analyzing the solid phases 
obtained in aqueous and SIF media at the end of the experiment by FT-IR (Figure S2 of Supporting 
Information)
Interestingly, the feasibility of salt formation constitutes an advantageous strategy to drug solubility 
enhancement in physiological acid conditions, which could improve the oral bioavailability of ABZ, 
an BCS class II drug.
Table 1. Summary of ABZ-Cl solubility studies.
Solution Apparent Solubility (µg/mL)
Water 100 ± 4
SFG 1360 ± 130
SFI 6,2 ± 0,4
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Figure 12. Solubility of ABZ I, ABZ II and ABZ-Cl in water, SGF and SIF, indicating the final pH 
values of the solution phases.
4. CONCLUSIONS 
Important information on a pharmaceutical salt obtained by using a simple and reproducible 
crystallization method was reported. ABZ-Cl was exhaustively characterized using diverse 
techniques, providing detailed data on the new solid form. Single-crystal X-ray diffraction data are 
reported for the first time, highlighting important π- π intermolecular interactions and confirming that 
all nitrogen atoms are protonated, in agreement with the salt formation. Spectroscopic techniques, 
together with thermal and microscopic methods, determined significant differences between ABZ-
Cl and the desmotropes ABZ I and II previously reported. Raman and FT-IR studies evidenced that 
the N of the carbamate moiety is involved in salt formation, also confirmed by 2D ssNMR, while 
EDS/SEM analysis supported the fact that Cl is an element of the solid. In addition, the salt showed 
physical stability at room temperature. The solubility studies have demonstrated the increasing 
solubilizing effect of the salt over the pure ABZ. Therefore, ABZ-Cl offers an alternative in the 
development of new and enhanced formulations of the drug, improving its therapeutic response due 
to an enhanced solubility. 
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Supporting Information. This report showed the quaternary carbon edition spectrum for ABZ-Cl 
(Figure S1) and the FT-IR spectra of solid phase at the end of the solubility assays (Figure S2). 
Moreover, the crystal data and structure refinement for ABZ-Cl (Table S1), the 13C chemical shifts 
for the assigned resonances (Table S2), the 1H chemical shifts extracted from the correlations in the 
HETCOR spectrum (Table S3) and the assignment of the FT-IR bands (Table S4) are shown.
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A pharmaceutical salt of albendazole was obtained and characterized by X-ray diffraction, magic 
angle spinning solid-state nuclear magnetic resonance spectroscopy, Raman and Fourier transform 
infrared spectroscopies, thermal analysis, energy-dispersive X-ray spectroscopy and scanning 
electron microscopy. The studies showed the participation of the carbamate moiety in the salt 
formation. A significant increase in the Albendazole solubility was determined.
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